“What’s New in Alzheimer’s Disease”
Event Navigation
HealthTrust presents...”What’s New in Alzheimer’s Disease”
Please Note: Continuing education credit is only available to those attending the session live. CE credit is not available when accessing the program on demand.
Alzheimer’s disease is a progressive neurological disorder and is the most common cause of dementia. Aducanumab is the first Alzheimer’s medication with potential disease-modifying effects to gain approval from the Food and Drug Administration. With the approval of aducanumab, a new class of Alzheimer’s medications was introduced, anti‐amyloid therapies. Medications in this class target the fundamental pathophysiology of the disease, the accumulation of amyloid plaques in the brain. This presentation will review the current treatment modalities of Alzheimer’s disease and will evaluate the literature on emerging therapies for Alzheimer’s disease management.
Learning Objectives for Pharmacists & Nurses | At the end of this session, participants should be able to:
- Recall current treatment modalities for Alzheimer’s Disease
- Recognize findings in the current literature on emerging therapies for Alzheimer’s disease management
- Identify potential benefits and risks of new therapies for Alzheimer’s disease
Learning Objectives for Pharmacy Techs | At the end of this session, participants should be able to:
- Define dementia and Alzheimer’s disease
- Identify medications for the management of Alzheimer’s disease
- Recognize preparations and storage recommendations for Alzheimer’s disease
Leah Leszcynski, PharmD | PGY-2 Geriatric Pharmacy Resident | Cooperman Saint Barnabas Medical Center
Target Audience: Pharmacists, Pharmacy Techs & Nurses
Continuing Education Information: 1.0 contact hours approved for Nurses and for Pharmacists. Belmont University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The ACPE Universal Activity Numbers for this activity are 0863-9999-22-036-L01-P for pharmacists and 0863-9999-22-036-L01-T for pharmacy technicians. The activity is approved for 1 hour of continuing education credit to nurses and pharmacists who attend the webinar and complete the online evaluation. Pfiedler Education is a division of AORN, provider approved by the California Board of Registered Nursing, Provider Number CEP13019, for 1 contact hour. 1.0 contact hours approved for Nurses.
Note about CE credit: If you plan to obtain credit for a live session, stay until the end of the presentation to receive the verification code you will need to obtain the continuing education credit. CE credit is individual. No group credit is available. Each person must register for a webinar and attend the webinar in its entirety in order to receive an email after the event with instructions on how to apply for continuing education credit. Attendees should not share the code or forward the email to others who did not actually attend the program. If they are not able to be verified on our webinar provider reports and registration list they will not receive credit. If you are joining only by phone, you will not be eligible for credit. You must also log in and join the visual portion of the webinar to be part of our CE provider-required reporting.
